0001628280-24-000052.txt : 20240102
0001628280-24-000052.hdr.sgml : 20240102
20240102160441
ACCESSION NUMBER: 0001628280-24-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231228
FILED AS OF DATE: 20240102
DATE AS OF CHANGE: 20240102
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schaeffer Orlov S Nicole
CENTRAL INDEX KEY: 0001401017
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 24502373
MAIL ADDRESS:
STREET 1: INSMED INCORPORATED
STREET 2: 10 FINDERNE AVENUE
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED Inc
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-977-9900
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: INSMED INC
DATE OF NAME CHANGE: 20000128
4
1
wk-form4_1704229471.xml
FORM 4
X0508
4
2023-12-28
0
0001104506
INSMED Inc
INSM
0001401017
Schaeffer Orlov S Nicole
700 US 202/206
BRIDGEWATER
NJ
08807
0
1
0
0
Chief People Strategy Officer
1
Common Stock
2023-12-28
4
M
0
22288
20.49
A
116837
D
Common Stock
2023-12-28
4
S
0
22288
32
D
94549
D
Stock Option (right to buy)
20.49
2023-12-28
4
M
0
22288
0
D
2024-01-04
Common Stock
22288
503
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Includes 1,024 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
Stock options granted under the Company's 2013 Incentive Plan. The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
/s/ S. Nicole Schaeffer, by Michael Smith as Attorney in Fact
2024-01-02